-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2019 to Q1 2024.
- Taysha Gene Therapies, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$19.8M, a 1.92% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$73M, a 17.4% increase from 2022.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$88.4M, a 24.5% increase from 2021.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$117M, a 281% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)